Association of high serum soluble interleukin 2 receptor levels with risk of adverse events in cardiac sarcoidosis.

Yuta KobayashiTakuma SatoToshiyuki NagaiKenji HirataSatonori TsunetaYoshiya KatoHirokazu KomoriyamaKiwamu KamiyaTakao KonishiKazunori OmoteHiroshi OhiraKohsuke KudoSatoshi KonnoToshihisa Anzai

Published in: ESC heart failure (2021)

Increased sIL-2R is associated with worse long-term clinical outcomes accompanied by increased systemic inflammatory activity in CS patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
oxidative stress
heart failure